Trials / Completed
CompletedNCT05016232
Adaptive Intervention to Facilitate PrEP Uptake/Adherence Among Transgender Women
Developing and Pilot Testing an Adaptive Intervention to Facilitate PrEP Uptake and Maximize PrEP Adherence Among At-Risk Transgender Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 123 (actual)
- Sponsor
- University of California, Los Angeles · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
"PrEP N' Shine" is a two-stage randomized controlled pilot trial which utilizes a behavioral intervention to optimize the uptake and adherence of Pre-exposure Prophylaxis (PrEP) in Transgender women (TGW).
Detailed description
The "PrEP N' Shine" package includes two behavioral intervention components: 1. Peer-led, strengths-based case management (SBCM) for PrEP linkage and uptake, and 2. A resource-efficient, adaptive "stepped-care" technology and counseling intervention that addresses individualized barriers to optimal use. Stage 1: TGW will be equally randomized to receive either the strengths-based case management or standard of care referral to PrEP clinic. Stage 2: Those from stage 1 who initiate PrEP , regardless of stage 1 randomization condition, will then be equally randomized to either the "PrEP N' Shine" adherence intervention or standard of care comparison condition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | PrEP N' Shine: Strength Based Case Management (Stage 1) | Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications. |
| BEHAVIORAL | PrEP N' Shine: Stepped Adherence Training and Counseling (Stage 2) | 1. Initially TGW in this arm will receive daily 2-way gender-affirming text message reminders, and 2. Then those continuing to have poor adherence will receive the 4 (once per week for 3 to 4 weeks) more intensive counseling session with a clinical interventionist. |
Timeline
- Start date
- 2022-10-18
- Primary completion
- 2024-05-31
- Completion
- 2024-06-30
- First posted
- 2021-08-23
- Last updated
- 2024-07-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05016232. Inclusion in this directory is not an endorsement.